Chemoproteomic Profiling Reveals that Anti-Cancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3.

Belcher, Bridget P; Machicao, Paulo A; Tong, Binqi; Ho, Emily; Friedli, Julia; So, Brian; Bui, Helen; Isobe, Yosuke; Maimone, Thomas J; Nomura, Daniel K

Belcher, Bridget P; Machicao, Paulo A; Tong, Binqi; Ho, Emily; Friedli, Julia; So, Brian; Bui, Helen; Isobe, Yosuke; Maimone, Thomas J; Nomura, Daniel K.

Afiliación

Belcher BP; Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720 USA.
Machicao PA; Novartis-Berkeley Translational Chemical Biology Institute.
Tong B; Innovative Genomics Institute, Berkeley, CA 94704 USA.
Ho E; Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720 USA.
Friedli J; Novartis-Berkeley Translational Chemical Biology Institute.
So B; Innovative Genomics Institute, Berkeley, CA 94704 USA.
Bui H; Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720 USA.
Isobe Y; Novartis-Berkeley Translational Chemical Biology Institute.
Maimone TJ; Innovative Genomics Institute, Berkeley, CA 94704 USA.
Nomura DK; Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720 USA.

bioRxiv ; 2023 Feb 11.

Article en En | MEDLINE | ID: mdl-36798342

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google